NCT04609683Completed
Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure
Introductory Non-Clinical and Clinical Trial for Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure
Source: ClinicalTrials.gov · Last updated 29 Nov 2023
Brief summary (registry, in English)
Subjects will be consented to wear the AleriTM sensor prior to, during, and after an Electrophysiology Procedure. During this time, the system will measure the following parameters from subjects: HR, temperature, saline volume/rate, urine production volume, USG, BPO. Data will be retrospectively analyzed to determine if the system effectively operates under these conditions, and can effectively monitor hydration levels of subjects compared to currently available methods.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 19 (actual)
- First submitted
- 22 Oct 2020
- Start date
- 19 Sept 2022
- Primary completion date
- 21 Nov 2022
- Lead sponsor
- NYU Langone Health
- Diseases
- Heart failure
- NCT number
- NCT04609683
What you commit to
- Study type: Interventional
- Participants enrolled: 19
- From 19 Sept 2022 to the primary completion date, 21 Nov 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnant subjects
- Subjects who are participating in another clinical study that may affect the results of either study
- Subjects who are unwilling or unable to wear the sensor for a period of up to 14 hours
- Subjects who are considered by the principle investigator to be medically unsuitable for study participation
Who the study is looking for
- Patients with cardiac arrhythmias or other cardiac conditions that are scheduled for EP procedures.
- Subject is over 18 years of age at the time of consenting
- Subject and/or legally authorized representative is willing to undergo the informed consent process prior to enrollment in the study
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.